Literature DB >> 11411569

Screening of natural compounds for inhibitory activity on colon cancer cell migration.

M Ogasawara1, T Matsubara, H Suzuki.   

Abstract

We examined the effects of 75 kinds of natural compounds, such as alkaloids, phenylpropanoids, flavonoids, steroids and terpenoids on the in vitro migration and proliferation of colon 26-L5 cells, in comparison with anti-cancer drugs used for chemotherapy. Twenty-three of the 75 compounds inhibited markedly tumor cell migration. Among the 23 compounds, evodiamine showed the most potent and selective inhibitory activity on tumor cell migration with an IC50 value of 1.25 microg/ml, which was about 20 times lower than that for tumor cell proliferation. The migratory inhibition reached about 70% at 10 microg/ml of evodiamine. On the other hand, most of anti-cancer drugs tested, except for paclitaxel, had little effect on tumor cell migration at the concentrations strongly inhibiting tumor cell proliferation. Paclitaxel suppressed tumor cell migration in a concentration-dependent manner and achieved about 70% inhibition at 10 microg/ml with a marginal effect on cell proliferation. These results suggest that evodiamine and paclitaxel may be regarded as leading compounds for anti-metastatic agents acting through the inhibition of tumor cell migration without cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411569     DOI: 10.1248/bpb.24.720

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  14 in total

1.  In vitro anticancer activity of Anemopsis californica.

Authors:  Catherine N Kaminski; Seth L Ferrey; Timothy Lowrey; Leo Guerra; Severine VAN Slambrouck; Wim F A Steelant
Journal:  Oncol Lett       Date:  2010-07       Impact factor: 2.967

2.  Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.

Authors:  Le Shi; Fan Yang; Fei Luo; Yi Liu; Feng Zhang; Meijuan Zou; Qizhan Liu
Journal:  Tumour Biol       Date:  2016-07-23

3.  Preparation of evodiamine solid dispersions and its pharmacokinetics.

Authors:  H Xu; T Zhang; H Yang; X Xiao; Y Bian; D Si; C Liu
Journal:  Indian J Pharm Sci       Date:  2011-05       Impact factor: 0.975

4.  Long non-coding RNA deregulation in tongue squamous cell carcinoma.

Authors:  Wei Gao; Jimmy Yu-Wai Chan; Thian-Sze Wong
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

5.  Cell migration and invasion assays as tools for drug discovery.

Authors:  Keren I Hulkower; Renee L Herber
Journal:  Pharmaceutics       Date:  2011-03-11       Impact factor: 6.321

6.  Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment.

Authors:  Daniel S Reynolds; Kristie M Tevis; William A Blessing; Yolonda L Colson; Muhammad H Zaman; Mark W Grinstaff
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

7.  The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.

Authors:  Junyu Xue; Shiyong Li; Peijie Shi; Mengke Chen; Shuang Yu; Shubin Hong; Yanbing Li; Rengyun Liu; Haipeng Xiao
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

8.  Dynamics of tumor hypoxia in response to patupilone and ionizing radiation.

Authors:  Katrin Orlowski; Carla Rohrer Bley; Martina Zimmermann; Van Vuong; Daniel Hug; Alex Soltermann; Angela Broggini-Tenzer; Martin Pruschy
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

9.  Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells.

Authors:  Zhang-Feng Zhong; Wen Tan; Sheng-Peng Wang; Wen-An Qiang; Yi-Tao Wang
Journal:  Sci Rep       Date:  2015-11-10       Impact factor: 4.379

Review 10.  Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa.

Authors:  Junlin Jiang; Changping Hu
Journal:  Molecules       Date:  2009-05-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.